Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Th17 cell differentiation	7/107	6.81794567632791e-12	5.999792195168561e-10	185.92	-436.38402493545493	CD4;FOXP3;IKBKG;IL17A;IL2RA;NFKB1;STAT3
KEGG_2021_Human	Measles	5/139	3.301250436176135e-07	1.4525501919174994e-05	59.208955223880594	-175.30198917758304	IKBKG;IL2RA;NFKB1;STAT3;TNFAIP3
KEGG_2021_Human	Inflammatory bowel disease	4/65	7.733227471018954e-07	2.2684133914988932e-05	87.50819672131148	-195.3419859289311	FOXP3;IL17A;NFKB1;STAT3
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	4/89	2.7491085630604124e-06	5.02079842461372e-05	62.61176470588235	-150.9687540546772	CD4;IKBKG;NFKB1;STAT3
KEGG_2021_Human	IL-17 signaling pathway	4/94	3.423271653145718e-06	5.02079842461372e-05	59.096296296296295	-144.19803777501954	IKBKG;IL17A;NFKB1;TNFAIP3
KEGG_2021_Human	Th1 and Th2 cell differentiation	4/92	3.140387248917198e-06	5.02079842461372e-05	60.45454545454545	-146.83106583854573	CD4;IKBKG;IL2RA;NFKB1
KEGG_2021_Human	Acute myeloid leukemia	3/67	6.278481738010982e-05	0.0006925701139734992	53.598214285714285	-98.46843432757142	IKBKG;NFKB1;STAT3
KEGG_2021_Human	Adipocytokine signaling pathway	3/69	6.857856994284154e-05	0.0006925701139734992	51.96103896103896	-96.07609532933417	IKBKG;NFKB1;STAT3
KEGG_2021_Human	Epstein-Barr virus infection	4/202	7.083103438365334e-05	0.0006925701139734992	26.4983164983165	-72.60755777125968	IKBKG;NFKB1;STAT3;TNFAIP3
KEGG_2021_Human	Pancreatic cancer	3/76	9.159620399517935e-05	0.000776667635061371	46.93737769080235	-88.55605413655218	IKBKG;NFKB1;STAT3
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	4/219	9.708345438267137e-05	0.000776667635061371	24.350387596899225	-67.12577033726024	CD4;IKBKG;IL2RA;NFKB1
KEGG_2021_Human	NF-kappa B signaling pathway	3/104	0.0002329673917108638	0.0015770100361966165	33.806223479490804	-67.40758155759835	IKBKG;NFKB1;TNFAIP3
KEGG_2021_Human	T cell receptor signaling pathway	3/104	0.0002329673917108638	0.0015770100361966165	33.806223479490804	-67.40758155759835	CD4;IKBKG;NFKB1
KEGG_2021_Human	TNF signaling pathway	3/112	0.00029005838446074546	0.00170167585550304	31.293577981651374	-63.06696788213405	IKBKG;NFKB1;TNFAIP3
KEGG_2021_Human	Toxoplasmosis	3/112	0.00029005838446074546	0.00170167585550304	31.293577981651374	-63.06696788213405	IKBKG;NFKB1;STAT3
KEGG_2021_Human	Yersinia infection	3/137	0.0005248515914701949	0.002886683753086072	25.375266524520256	-52.38188378130509	CD4;IKBKG;NFKB1
KEGG_2021_Human	Hepatitis C	3/157	0.0007818177127513567	0.004047056395418787	22.024118738404454	-46.00245527612638	IKBKG;NFKB1;STAT3
KEGG_2021_Human	Hepatitis B	3/162	0.000856615716023289	0.004187899056113857	21.318059299191376	-44.62403509135876	IKBKG;NFKB1;STAT3
KEGG_2021_Human	Primary immunodeficiency	2/38	0.0009469209383415865	0.004385739082845242	55.77777777777778	-62.87407127134141	CD4;IKBKG
KEGG_2021_Human	NOD-like receptor signaling pathway	3/181	0.0011822602400977265	0.0052019450564299964	18.996789727126806	-40.00053498134924	IKBKG;NFKB1;TNFAIP3
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	3/193	0.0014235649100074823	0.005694259640029929	17.769924812030077	-37.496518500419114	IKBKG;NFKB1;STAT3
KEGG_2021_Human	Chemokine signaling pathway	3/192	0.001402358175894933	0.005694259640029929	17.866213151927436	-37.69462705671507	IKBKG;NFKB1;STAT3
KEGG_2021_Human	Viral carcinogenesis	3/203	0.0016469262374030193	0.006301282995281117	16.86	-35.61063787888018	IKBKG;NFKB1;STAT3
KEGG_2021_Human	Human immunodeficiency virus 1 infection	3/212	0.0018659404176712966	0.006838762881259511	16.115516062884485	-34.04865723073064	CD4;IKBKG;NFKB1
KEGG_2021_Human	Lipid and atherosclerosis	3/215	0.0019428303639941794	0.006838762881259511	15.881401617250674	-33.55383703082171	IKBKG;NFKB1;STAT3
KEGG_2021_Human	Human cytomegalovirus infection	3/225	0.00221350447353219	0.007491861295032026	15.146718146718147	-31.989452913184095	IKBKG;NFKB1;STAT3
KEGG_2021_Human	Coronavirus disease	3/232	0.0024164136009215383	0.007875718403003532	14.670617592014972	-30.966105875434415	IKBKG;NFKB1;STAT3
KEGG_2021_Human	Cytosolic DNA-sensing pathway	2/63	0.00258752682682323	0.008132227170015865	32.8155737704918	-41.182346051003734	IKBKG;NFKB1
KEGG_2021_Human	Pathways in cancer	4/531	0.0028173482711087343	0.008549194753709263	9.539531941808981	-25.060320343159585	IKBKG;IL2RA;NFKB1;STAT3
KEGG_2021_Human	RIG-I-like receptor signaling pathway	2/70	0.0031848593502604382	0.008758363213216205	29.41176470588235	-37.553176952571945	IKBKG;NFKB1
KEGG_2021_Human	Epithelial cell signaling in Helicobacter pylori infection	2/70	0.0031848593502604382	0.008758363213216205	29.41176470588235	-37.553176952571945	IKBKG;NFKB1
KEGG_2021_Human	Prolactin signaling pathway	2/70	0.0031848593502604382	0.008758363213216205	29.41176470588235	-37.553176952571945	NFKB1;STAT3
KEGG_2021_Human	Chronic myeloid leukemia	2/76	0.0037436519554145367	0.009983071881105431	27.006756756756758	-34.90410589940028	IKBKG;NFKB1
KEGG_2021_Human	B cell receptor signaling pathway	2/81	0.004241897027183041	0.010979027599767871	25.281645569620252	-32.95657984925952	IKBKG;NFKB1
KEGG_2021_Human	Cytokine-cytokine receptor interaction	3/295	0.004778958454651453	0.012015666971695082	11.412915851272016	-23.74866982495136	CD4;IL17A;IL2RA
KEGG_2021_Human	Small cell lung cancer	2/92	0.005440715912052039	0.013299527785016096	22.16111111111111	-29.32328202848766	IKBKG;NFKB1
KEGG_2021_Human	Prostate cancer	2/97	0.006031622120792857	0.01434547963864247	20.981578947368423	-27.909669646620806	IKBKG;NFKB1
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	2/100	0.006399778215208473	0.014440525203547322	20.331632653061224	-27.120602948412195	NFKB1;STAT3
KEGG_2021_Human	Hematopoietic cell lineage	2/99	0.006275930773922806	0.014440525203547322	20.54381443298969	-27.37901341152302	CD4;IL2RA
KEGG_2021_Human	Toll-like receptor signaling pathway	2/104	0.006906399428166279	0.014470551182824583	19.524509803921568	-26.130280011490946	IKBKG;NFKB1
KEGG_2021_Human	Chagas disease	2/102	0.006650847322673755	0.014470551182824583	19.92	-26.61700675496218	IKBKG;NFKB1
KEGG_2021_Human	C-type lectin receptor signaling pathway	2/104	0.006906399428166279	0.014470551182824583	19.524509803921568	-26.130280011490946	IKBKG;NFKB1
KEGG_2021_Human	HIF-1 signaling pathway	2/109	0.007564767477927373	0.015129534955854746	18.600467289719628	-24.98176436194636	NFKB1;STAT3
KEGG_2021_Human	Insulin resistance	2/108	0.007430876215757518	0.015129534955854746	18.778301886792452	-25.204052222837845	NFKB1;STAT3
KEGG_2021_Human	PI3K-Akt signaling pathway	3/354	0.007955391465782094	0.01555720997752943	9.422466422466423	-19.140881053489387	IKBKG;IL2RA;NFKB1
KEGG_2021_Human	Osteoclast differentiation	2/127	0.010161324318032567	0.01943905521710578	15.886	-21.510038502238015	IKBKG;NFKB1
KEGG_2021_Human	Fluid shear stress and atherosclerosis	2/139	0.012084353093672291	0.022626022813684293	14.472627737226277	-19.639406588988233	IKBKG;NFKB1
KEGG_2021_Human	Apoptosis	2/142	0.012588538285001706	0.023078986855836463	14.157142857142857	-19.21549786230027	IKBKG;NFKB1
KEGG_2021_Human	Necroptosis	2/159	0.015618487202540639	0.028049528037215846	12.597133757961783	-17.083187709957596	STAT3;TNFAIP3
KEGG_2021_Human	JAK-STAT signaling pathway	2/162	0.016183180370760934	0.028482397452539242	12.35625	-16.748364182562245	IL2RA;STAT3
KEGG_2021_Human	Influenza A	2/172	0.01812904275363809	0.031281485535689255	11.614705882352942	-15.707848772731996	IKBKG;NFKB1
KEGG_2021_Human	Pathogenic Escherichia coli infection	2/197	0.0234094024256627	0.03961591179727533	10.093589743589744	-13.525208778126117	IKBKG;NFKB1
KEGG_2021_Human	Ras signaling pathway	2/232	0.03174764714886429	0.052713074511321845	8.519565217391305	-11.194266119915625	IKBKG;NFKB1
KEGG_2021_Human	Chemical carcinogenesis	2/239	0.03354092254711208	0.05465928118788635	8.26054852320675	-10.803362590978235	NFKB1;STAT3
KEGG_2021_Human	Shigellosis	2/246	0.035374463538784595	0.056599141662055354	8.01639344262295	-10.432967830507518	IKBKG;NFKB1
KEGG_2021_Human	Salmonella infection	2/249	0.03617242514905692	0.05684238237708945	7.915991902834008	-10.280113155611538	IKBKG;NFKB1
KEGG_2021_Human	MAPK signaling pathway	2/294	0.04897898942595734	0.07561668542954818	6.657534246575342	-8.337786615237395	IKBKG;NFKB1
KEGG_2021_Human	MicroRNAs in cancer	2/310	0.0538910819803677	0.08176577955641996	6.298701298701299	-7.775300015246377	NFKB1;STAT3
KEGG_2021_Human	Cocaine addiction	1/49	0.05906133610748362	0.08809148436370438	18.564814814814813	-10.829316375605623	NFKB1
KEGG_2021_Human	Human papillomavirus infection	2/331	0.06060431633754296	0.08888633062839635	5.880699088145897	-7.115618067766183	IKBKG;NFKB1
KEGG_2021_Human	Legionellosis	1/57	0.06840002327828267	0.0986754434178504	15.896825396825397	-9.424000900813787	NFKB1
KEGG_2021_Human	Non-small cell lung cancer	1/72	0.0856855265026792	0.12161816664896402	12.514866979655713	-7.534346814915346	STAT3
KEGG_2021_Human	Antigen processing and presentation	1/78	0.09251851170984433	0.1252558312379431	11.531024531024531	-6.958150954500108	CD4
KEGG_2021_Human	Pertussis	1/76	0.09024597396088518	0.1252558312379431	11.841481481481482	-7.141387005986298	NFKB1
KEGG_2021_Human	Leishmaniasis	1/77	0.09138288226635771	0.1252558312379431	11.68421052631579	-7.04872976578505	NFKB1
KEGG_2021_Human	Rheumatoid arthritis	1/93	0.1094003568916107	0.1458671425221476	9.632850241545894	-5.8073541800756905	IL17A
KEGG_2021_Human	Viral protein interaction with cytokine and cytokine receptor	1/100	0.11718138394436346	0.15226967528706875	8.94388327721661	-5.375723879218761	IL2RA
KEGG_2021_Human	Amoebiasis	1/102	0.11939326812281527	0.15226967528706875	8.764576457645765	-5.262086311101535	NFKB1
KEGG_2021_Human	Longevity regulating pathway	1/102	0.11939326812281527	0.15226967528706875	8.764576457645765	-5.262086311101535	NFKB1
KEGG_2021_Human	Herpes simplex virus 1 infection	2/498	0.12295964829332588	0.15457784356875254	3.816532258064516	-3.814605004177811	IKBKG;NFKB1
KEGG_2021_Human	Sphingolipid signaling pathway	1/119	0.13799386385009413	0.16634876738093538	7.4858757062146895	-4.435243302362896	NFKB1
KEGG_2021_Human	Neurotrophin signaling pathway	1/119	0.13799386385009413	0.16634876738093538	7.4858757062146895	-4.435243302362896	NFKB1
KEGG_2021_Human	Growth hormone synthesis, secretion and action	1/119	0.13799386385009413	0.16634876738093538	7.4858757062146895	-4.435243302362896	STAT3
KEGG_2021_Human	Relaxin signaling pathway	1/129	0.1487694756391342	0.17691505211140282	6.892361111111111	-4.041189892105298	NFKB1
KEGG_2021_Human	FoxO signaling pathway	1/131	0.1509099928727911	0.17706772497074155	6.7846153846153845	-3.968927686510734	STAT3
KEGG_2021_Human	Signaling pathways regulating pluripotency of stem cells	1/143	0.163651680714637	0.18949141977484285	6.2018779342723	-3.57415842622014	STAT3
KEGG_2021_Human	Cell adhesion molecules	1/148	0.16890973234869874	0.19303969411279856	5.987150415721844	-3.427000500776257	CD4
KEGG_2021_Human	Cellular senescence	1/156	0.17726075583432344	0.19745501915722105	5.672401433691756	-3.209640069203435	NFKB1
KEGG_2021_Human	Non-alcoholic fatty liver disease	1/155	0.17622102470306392	0.19745501915722105	5.70995670995671	-3.235678410841787	NFKB1
KEGG_2021_Human	Tuberculosis	1/180	0.20186266926868635	0.222048936195555	4.896958410924891	-2.6658400097237527	NFKB1
KEGG_2021_Human	Neutrophil extracellular trap formation	1/189	0.21091631211370437	0.22914364772846896	4.657210401891253	-2.4954112144854435	NFKB1
KEGG_2021_Human	Transcriptional misregulation in cancer	1/192	0.21391358807496763	0.22956580183655065	4.5823152995927865	-2.441961042053517	NFKB1
KEGG_2021_Human	Proteoglycans in cancer	1/205	0.22678373523038298	0.23758296071754406	4.283224400871459	-2.2275706216550177	STAT3
KEGG_2021_Human	Diabetic cardiomyopathy	1/203	0.22481613944093093	0.23758296071754406	4.326732673267327	-2.2588473265567357	NFKB1
KEGG_2021_Human	cAMP signaling pathway	1/216	0.23752539179620868	0.24590864091842782	4.058397932816537	-2.065502377074288	NFKB1
KEGG_2021_Human	Endocytosis	1/252	0.27174750318495006	0.27806721256134426	3.4603806994245243	-1.6315316807371463	IL2RA
KEGG_2021_Human	Alzheimer disease	1/369	0.3736370340305108	0.3779317125825856	2.32487922705314	-0.8103995559567543	NFKB1
KEGG_2021_Human	Pathways of neurodegeneration	1/475	0.45466905008847364	0.45466905008847364	1.7801218940459447	-0.4367315309409891	NFKB1
